-
1
-
-
11144354035
-
Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease
-
Van Camp G, Flamez A, Cosyns B, Weytjens C, Muyldermans L, Van Zandijcke M et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet 2004;363:1179-83.
-
(2004)
Lancet
, vol.363
, pp. 1179-1183
-
-
Van Camp, G.1
Flamez, A.2
Cosyns, B.3
Weytjens, C.4
Muyldermans, L.5
Van Zandijcke, M.6
-
2
-
-
33845986031
-
Dopamine agonists and the risk of cardiac-valve regurgitation
-
Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiac-valve regurgitation. N Engl J Med 2007;356:29-38.
-
(2007)
N Engl J Med
, vol.356
, pp. 29-38
-
-
Schade, R.1
Andersohn, F.2
Suissa, S.3
Haverkamp, W.4
Garbe, E.5
-
3
-
-
33845974147
-
Valvular heart disease and the use of dopamine agonists for Parkinson's disease
-
Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007;356:39-46.
-
(2007)
N Engl J Med
, vol.356
, pp. 39-46
-
-
Zanettini, R.1
Antonini, A.2
Gatto, G.3
Gentile, R.4
Tesei, S.5
Pezzoli, G.6
-
4
-
-
33846017361
-
Drugs and valvular heart disease
-
Roth BL. Drugs and valvular heart disease. N Engl J Med 2007;356:6-9.
-
(2007)
N Engl J Med
, vol.356
, pp. 6-9
-
-
Roth, B.L.1
-
5
-
-
30344481661
-
Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease
-
Muraki M, Mikami T, Kitaguchi M, Sugawara T, Isonishi K, Kaneko S et al. Effects of low-dose pergolide therapy on cardiac valves in patients with Parkinson's disease. J Cardiol 2005;46:221-7.
-
(2005)
J Cardiol
, vol.46
, pp. 221-227
-
-
Muraki, M.1
Mikami, T.2
Kitaguchi, M.3
Sugawara, T.4
Isonishi, K.5
Kaneko, S.6
-
6
-
-
33748363728
-
Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists
-
Kim JY, Chung EJ, Park SW, Lee WY. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists. Mov Disord 2006;21:1261-4.
-
(2006)
Mov Disord
, vol.21
, pp. 1261-1264
-
-
Kim, J.Y.1
Chung, E.J.2
Park, S.W.3
Lee, W.Y.4
-
7
-
-
36348942365
-
Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide
-
Ruzicka E, Linkova H, Penicka M, Ulmanova O, Novakova L, Roth J. Low incidence of restrictive valvulopathy in patients with Parkinson's disease on moderate dose of pergolide. J Neurol 2007;254:1575-8.
-
(2007)
J Neurol
, vol.254
, pp. 1575-1578
-
-
Ruzicka, E.1
Linkova, H.2
Penicka, M.3
Ulmanova, O.4
Novakova, L.5
Roth, J.6
-
8
-
-
49249138931
-
The frequency of cardiac valvular regurgitation in Parkinson's disease
-
Yamashiro K, Komine-Kobayashi M, Hatano T, Urabe T, Mochizuki H, Hattori N et al. The frequency of cardiac valvular regurgitation in Parkinson's disease. Mov Disord 2008;23:935-41.
-
(2008)
Mov Disord
, vol.23
, pp. 935-941
-
-
Yamashiro, K.1
Komine-Kobayashi, M.2
Hatano, T.3
Urabe, T.4
Mochizuki, H.5
Hattori, N.6
-
9
-
-
47049126778
-
Cabergoline and the risk of valvular lesions in endocrine disease
-
Lancellotti P, Livadariu E, Markov M, Daly A, Burlacu MC, Betea D et al. Cabergoline and the risk of valvular lesions in endocrine disease. Eur J Endocrinol 2008;159:1-5.
-
(2008)
Eur J Endocrinol
, vol.159
, pp. 1-5
-
-
Lancellotti, P.1
Livadariu, E.2
Markov, M.3
Daly, A.4
Burlacu, M.C.5
Betea, D.6
-
10
-
-
54949149373
-
High risk factors for valvular heart disease from dopamine agonists in Parkinson's disease
-
Oeda T, Masaki M, Yamamoto K, Mizuta E, Kuno S, Sawada H. High risk factors for valvular heart disease from dopamine agonists in Parkinson's disease. Parkinsonism Relat Disord 2007;13:S120.
-
(2007)
Parkinsonism Relat Disord
, vol.13
-
-
Oeda, T.1
Masaki, M.2
Yamamoto, K.3
Mizuta, E.4
Kuno, S.5
Sawada, H.6
-
11
-
-
34948817624
-
In vivo model of drug-induced valvular heart disease in rats: Pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology
-
Droogmans S, Franken PR, Garbar C, Weytjens C, Cosyns B, Lahoutte T et al. In vivo model of drug-induced valvular heart disease in rats: pergolide-induced valvular heart disease demonstrated with echocardiography and correlation with pathology. Eur Heart J 2007;28:2156-62.
-
(2007)
Eur Heart J
, vol.28
, pp. 2156-2162
-
-
Droogmans, S.1
Franken, P.R.2
Garbar, C.3
Weytjens, C.4
Cosyns, B.5
Lahoutte, T.6
-
12
-
-
21644477054
-
Pergolide associated valvulopathy: Critical analysis of the literature and practical recommendations
-
Corvol JC, Schupbach M, Bonnet AM. Pergolide associated valvulopathy: critical analysis of the literature and practical recommendations. Rev Neurol (Paris) 2005;161:637-43.
-
(2005)
Rev Neurol (Paris)
, vol.161
, pp. 637-643
-
-
Corvol, J.C.1
Schupbach, M.2
Bonnet, A.M.3
|